Your Top 50 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study
Emmanuel S. Antonarakis, Josep Maria Piulats, Marine Gross‐Goupil, Jeffrey C.H. Goh, Kristiina Ojamaa, Christopher J. Hoimes and 18 more
- Rank
- 13 of 507
- Percentile
- top 2.6%
- Where
- Journal of Clinical Oncology, 2019
- Citations
- 736
From the 2019 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.